In 2012, Timothy Whitten earned $500.00K in total compensation at Insmed, including $400.00K salary and $100.00K bonus. Most recently acquired 7,500 shares in Jun 2012. Led Insmed as CEO for 1 years.
Compensation History
Annual executive compensation data for Timothy Whitten, including salary, bonuses, and stock awards.
Year
2012
Total Compensation
$500.00K
Salary
$400.00K
Bonus
$100.00K
Other
$0.00
Salary
$400.00KBoard Justification
The compensation philosophy is designed to attract, retain, and motivate highly qualified executives, aligning their interests with those of shareholders through performance-based compensation.
Bonus
$100.00KBoard Justification
The bonus is based on the achievement of specific performance metrics set by the Board for the fiscal year 2012, which include milestones related to clinical trials and corporate objectives.
Other Compensation
$0.00Board Justification
No additional compensation was reported outside of salary and bonus.
Restricted Stock
Board Justification
No stock was vested in 2012 as the focus was on performance-based cash bonuses and salary.
Performance Metrics
The performance metrics for 2012 included successful completion of clinical trial milestones and maintaining appropriate capitalization.
Timothy Whitten
Ex-CEO of Insmed
Education
M.B.A. from University of Virginia
Field of Expertise
Healthcare & Life Sciences - Pharmaceuticals
Sector of Economy
Healthcare
Born
January 1, 1957 - 68 years ago
CEO of Insmed for
1 year 9 months (Dec 2010 - Sep 2012)
Previous Experience
President and Chief Executive Officer of Transave
Holdings
Track Timothy Whitten's stock holdings and portfolio value over time.
Insider Trading
Timothy Whitten's recent stock transactions, purchases, and sales filed with the SEC.
Rivals
Compare Timothy Whitten with competitor CEOs and industry peers.